Overall, the findings in this study revealed the novel effect of IL-33 in suppressing lupus onset in young NZB/W F1 mice, presumably through the protective anti-dsDNA IgM antibodies, IL-10-expressing Breg cells, and upregulation of alternatively-activated M2 macrophage-genes. Here, IL10 is linked to systemic lupus erythematosus.